TY - JOUR
KW - Adult
KW - Apgar Score
KW - Birth Weight/drug effects
KW - Buprenorphine/administration & dosage/adverse effects
KW - Delivery, Obstetric/statistics & numerical data
KW - Dose-Response Relationship, Drug
KW - Female
KW - Gestational Age
KW - Humans
KW - Infant, Newborn
KW - Length of Stay/statistics & numerical data
KW - Maine/epidemiology
KW - Male
KW - Narcotic Antagonists/adverse effects
KW - Neonatal Abstinence Syndrome/epidemiology
KW - Opiate Substitution Treatment/adverse effects
KW - Pregnancy
KW - Prenatal Exposure Delayed Effects/epidemiology
KW - Retrospective Studies
KW - Young Adult
AU - A. B. O'Connor
AU - L. O'Brien
AU - W. A. Alto
A1 - 
BT - European addiction research
C5 - Opioids & Substance Use; Healthcare Disparities
CP - 3
CY - Switzerland
DO - 10.1159/000441220
IS - 3
JF - European addiction research
PB - S. Karger AG, Basel
PP - Switzerland
PY - 2016
SN - 1421-9891; 1022-6877
SP - 127
EP - 130
EP - 
T1 - Maternal Buprenorphine Dose at Delivery and Its Relationship to Neonatal Outcomes
T2 - European addiction research
TI - Maternal Buprenorphine Dose at Delivery and Its Relationship to Neonatal Outcomes
U1 - Opioids & Substance Use; Healthcare Disparities
U2 - 26491960
U3 - 10.1159/000441220
VL - 22
VO - 1421-9891; 1022-6877
Y1 - 2016
ER -